Taiwanese company Pou Chen Corp halted operations at its plant in the Vietnamese capital of Ho Chih Minh City last wek as a result of COVID-19 concerns. The factory, which produces footwear for Nike and Adidas, took the decision as COVID-19 cases continue to surge in Vietnam's business hub.
Vietnam's...
After 33 years of operational difficulties, American vaccine development company Novavax has finally received approval for its COVID-19 vaccine shot. According to testing results, the Novavax vaccine has efficacy rates that are of a similar level to the vaccines developed by Pfizer and BioNTech as well as Moderna.
As the...
The Canadian province of Ontario revealed its plan to lift several COVID-19 health restrictions. Starting from Saturday at midnight, concert venues, theatres, sports stadiums, and other spectator facilities will be permitted to host a higher capacity of spectators than was previously permitted. Spectators will still, however, be required to...
Healthcare and science provisions supplier Thermo Fisher Scientific Inc has decided to pursue the purchase of clinical and research provider PPD Inc in a deal worth $17.4 billion. This promises to be yet another game-changing deal in the health care sector, which has soared since the start of the...
With multinational pharmaceutical company Johnson & Johnson revealing its latest coronavirus vaccine data, U.S. stock indexes fell while going into the weekend. According to its latest report, Johnson & Johnson's coronavirus vaccine candidate has proven to be 72% effective in the United States and 66% on a global scale.
These...
Pfizer Inc and BioNTech SE revealed on Wednesday that they've completed a deal with the South African Biovac Institute to process and distribute approximately 100 million COVID-19 vaccines to members of the African Union. While production will begin in 2022, equipment installations, on-site developments, and the transfer of technology...
Multinational science and technology company Merck KGgA announced on Monday that it has closed a deal with Swiss biotech company Debiopharm to develop and market its Xevinapant drug for head and neck cancer. The deal is estimated to be worth 900 million euros ($1.08 billion).
The terms of the deal...
Merck & Co announced on Wednesday that it has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) to allow other companies to manufacture generic versions of the U.S. drugmaker's oral antiviral COVID-19 treatment. The agreement would be valid in 105 low and middle-income countries.
The experimental...
Japanese shares rose significantly on Friday morning following the advancements in the country's vaccination rollout which is paving the way to a smooth economic recovery. As a result, investors moved to scoop up stocks that had previously been sold off due to the wavering economic uncertainty in the previous...
The Colombian government announced on Saturday that it is due to receive an initial order of 4.4 million doses of coronavirus vaccines from the World Health Organization-backed COVAX mechanism.
President Ivan Duque addressed the nation on television, explaining that this delivery would include a combination of vaccines developed by Pfizer...